{"id":"CHEMBL1079604","canonicalSmiles":"Cc1cc(C)cc(OCC2CNC(=O)O2)c1","inchiKey":"IMWZZHHPURKASS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METAXALONE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Metaxalone","Skelaxin"],"synonyms":["AHR-438","Flexura","Metaxalone","NSC-170959","Zorane"],"crossReferences":{"DailyMed":["metaxalone"],"PubChem":["144204981","170465241","26748938"],"Wikipedia":["Metaxalone"],"drugbank":["DB00660"],"chEBI":["6797"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL1128","canonicalSmiles":"CC[N+](C)(C)c1cccc(O)c1.[Cl-]","inchiKey":"BXKDSDJJOVIHMX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDROPHONIUM CHLORIDE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1104","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Camsilon","Edrophonium chloride","Edrophonium chloride preservative free","Enlon","Reversol","Tensilon","Tensilon preservative free"],"synonyms":["Antirex","Edrophone chloride","Edrophonii chloridum","Edrophonium Chloride","Edrophonium chloride","NSC-759577"],"crossReferences":{"PubChem":["144203689","170464801","26747508","26747509","50106293","50106294","50106295","56422101","855983"],"Wikipedia":["Edrophonium"],"chEBI":["4759"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1951."}
{"id":"CHEMBL1134","canonicalSmiles":"C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C.[Br-].[Br-]","inchiKey":"HLXQFVXURMXRPU-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"DECAMETHONIUM BROMIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1190","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Syncurine"],"synonyms":["Decamethonium Bromide","Decamethonium bromide","Decamethonium diiodide","Decamethonium iodide","NSC-23004"],"crossReferences":{"PubChem":["144205588","170465349","50106154","855712"],"Wikipedia":["Decamethonium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL115","canonicalSmiles":"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O","inchiKey":"CBVCZFGXHXORBI-PXQQMZJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDINAVIR","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crixivan"],"synonyms":["Crixivan","Indinavir","Indinavir anhydrous","Indinavir monohydrate","Indinavir system suitability","L-735524","MK-639"],"crossReferences":{"DailyMed":["indinavir%20sulfate"],"PubChem":["29215411"],"drugbank":["DB00224"],"chEBI":["44032"]},"childChemblIds":["CHEMBL1735"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for viral disease and hiv infection and has 9 investigational indications."}
{"id":"CHEMBL1200572","canonicalSmiles":"O=[Mg]","inchiKey":"CPLXHLVBOLITMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM OXIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mag ox","Mag-ox 400","Magdose","Magstar","Oromag 160","Oximag","Uro-mag"],"synonyms":["E-530","E530","Heavy magnesium oxide","INS NO.530","INS-530","Light magnesium oxide","Magnesia","Magnesia oxydata","Magnesii oxidum","Magnesium (as oxide)","Magnesium oxide","Magnesium oxide heavy","Magnesium oxide, heavy","Magnesium oxide, light"],"crossReferences":{"DailyMed":["magnesium%20oxide"],"Wikipedia":["Magnesium_oxide"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for iron deficiency anemia and constipation and has 4 investigational indications."}
{"id":"CHEMBL1200636","canonicalSmiles":"CN(C)CCC=C1c2ccccc2C=Cc2ccccc21.Cl","inchiKey":"VXEAYBOGHINOKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOBENZAPRINE HYDROCHLORIDE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL669","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amrix","Cyclobenzaprine hydrochloride","Flexeril"],"synonyms":["Cyclobenzaprine hcl","Cyclobenzaprine hydrochloride","MK-130","MK-130 HYDROCHLORIDE","MK-130 [AS THE BASE]","NSC-169900","NSC-173379","NSC-78206"],"crossReferences":{"DailyMed":["cyclobenzaprine%20hydrochloride"],"PubChem":["124891634","144203591","170464953","26748730","26748731","50106063","50107452","50107453","551139","56463037"],"chEBI":["3997"]},"linkedTargets":{"rows":["ENSG00000102468","ENSG00000147246"],"count":2},"linkedDiseases":{"rows":["HP_0001257","MONDO_0005277","HP_0003326","EFO_0009488","EFO_1000632","HP_0003394"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 5 approved and 1 investigational indication."}
{"id":"CHEMBL1200722","canonicalSmiles":"CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H](N3CC[N+](C)(C)CC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CC[N+](C)(C)CC1.[Br-].[Br-]","inchiKey":"TXWBOBJCRVVBJF-YTGGZNJNSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPECURONIUM BROMIDE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201206","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arduan"],"synonyms":["Pipecurium bromide","Pipecuronium bromide","Pipecuronium bromide anhydrous","Pipecuronium bromide dihydrate","Pipecuronium bromide hydrate","RGH 1106","RGH-1106"],"crossReferences":{"Wikipedia":["Pipecuronium_bromide"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990."}
{"id":"CHEMBL1200930","canonicalSmiles":"COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[n-]2)c1C.[Na+]","inchiKey":"KRCQSTCYZUOBHN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RABEPRAZOLE SODIUM","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1219","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aciphex","Aciphex sprinkle","Pariet","Rabeprazole sodium"],"synonyms":["E-3810","E-3810 SODIUM","Idiazole","LY-307640","LY-307640 SODIUM","LY307640 SODIUM","NSC-759270","Rabeprazole na","Rabeprazole sodium","Rabeprazole sodium salt","Sodium rabeprazole"],"crossReferences":{"DailyMed":["rabeprazole%20sodium"],"PubChem":["144205289","144212634","170464736","49666380"],"chEBI":["8769"]},"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","EFO_0009454","EFO_0010282","EFO_0003763","EFO_0004607","EFO_0007549","EFO_1000961","EFO_1001095","EFO_1001355"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL1201338","canonicalSmiles":"CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1","inchiKey":"SKYSRIRYMSLOIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOPENTOLATE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bell pentolate","Cyclopentolate"],"crossReferences":{"DailyMed":["cyclopentolate%20hydrochloride"],"drugbank":["DB00979"],"chEBI":["4024"]},"childChemblIds":["CHEMBL1200473"],"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_0005758","HP_0011499","HP_0000616","MONDO_0004892"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for mydriasis and has 2 investigational indications."}
{"id":"CHEMBL1201524","drugType":"Protein","blackBoxWarning":false,"name":"TECHNETIUM (99MTC) APCITIDE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acutect"],"synonyms":["(99MTC)-P246","99MTC-P246","Technetium (99mtc) apcitide","Technetium tc 99m apcitide","Technetium tc-99m apcitide","[99MTC]-P246"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1998."}
{"id":"CHEMBL1206","canonicalSmiles":"CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21","inchiKey":"CDOZDBSBBXSXLB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHOPROPAZINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ethopropazine","Parsidol","Profenamine"],"crossReferences":{"PubChem":["90341779"],"Wikipedia":["Profenamine"],"drugbank":["DB00392"],"chEBI":["313639"]},"childChemblIds":["CHEMBL1200970"],"linkedTargets":{"rows":["ENSG00000168539"],"count":1},"linkedDiseases":{"rows":["MONDO_0005180"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for parkinson disease."}
{"id":"CHEMBL1221660","canonicalSmiles":"CCOC(=O)N1CCC(Nc2cc(Cl)ccn2)CC1","inchiKey":"YQEYLCGMINXDBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1221660","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07306"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230023","canonicalSmiles":"CCC[C@H]1COc2ccsc2C(=N)N1","inchiKey":"JIIBOYBTIWHZFJ-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230023","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07001"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230333","canonicalSmiles":"O=C(O)CCCc1cccs1","inchiKey":"VYTXLSQVYGNWLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230333","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02434"],"chEBI":["40114"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232767","canonicalSmiles":"F","inchiKey":"KRHYYFGTRYWZRS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUORIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluoride"],"crossReferences":{"drugbank":["DB11072"],"chEBI":["29228"]},"childChemblIds":["CHEMBL1909275"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1234033","canonicalSmiles":"Nc1ncc(Cc2ccccc2)s1","inchiKey":"FJIMLXBJUVLMMN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234033","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08114"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235535","canonicalSmiles":"OCc1cccnc1","inchiKey":"MVQVNTPHUGQQHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOTINYL ALCOHOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Roniacol"],"synonyms":[".beta.-pyridylcarbinol","C10AD05","NSC-526046","NU-2121","Nicotinic alcohol","Nicotinyl Alcohol (Pyridylcarbinol)","Nicotinyl alcohol","Nicotinyl alcohol (pyridylcarbinol)","Nicotinyl alcohol tartrate","Pyridylcarbinol","Pyridylmethanol","RO 1-5155","RO-1-5155","RO-15155"],"crossReferences":{"PubChem":["144211156","170466803","29215333"],"drugbank":["DB04145"]},"childChemblIds":["CHEMBL1324760"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL12713","canonicalSmiles":"O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1","inchiKey":"GZKLJWGUPQBVJQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERTINDOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," Germany"," Italy"," Ireland"," Netherlands"," European Union"],"classes":["Cardiotoxicity"],"year":1998},"tradeNames":["Serlect"],"synonyms":["LU 23-174","LU-23-174","Serdolect","Sertindole","Zerdol"],"crossReferences":{"PubChem":["144206958","144206971","170465613"],"Wikipedia":["Sertindole"],"drugbank":["DB06144"],"chEBI":["9122"]},"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000147246"],"count":6},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002050","HP_0000726","EFO_0005407","EFO_0005230","EFO_0005411"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for psychosis and has 4 investigational indications. It was withdrawn in United Kingdom,  Germany,  Italy,  Ireland,  Netherlands and  European Union initially in 1998 due to Cardiotoxicity."}
{"id":"CHEMBL1301","canonicalSmiles":"N=C(N)c1ccc(/C=C/c2ccc(C(=N)N)cc2O)cc1","inchiKey":"TUESWZZJYCLFNL-DAFODLJHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYSTILBAMIDINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hydroxystilbamidine"],"crossReferences":{"PubChem":["124893257","29218047"],"Wikipedia":["Hydroxystilbamidine"],"drugbank":["DB14753"]},"childChemblIds":["CHEMBL2023895","CHEMBL1200847"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953."}
{"id":"CHEMBL1326877","canonicalSmiles":"COc1ccc(C(=O)c2ccccc2O)c(O)c1","inchiKey":"MEZZCSHVIGVWFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIOXYBENZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzophenone-8","Dioxybenzone","NSC-56769","Spectra-sorb uv 24"],"crossReferences":{"PubChem":["11112287","124882184","144203968","144208191","170465540","26748001","56463069"],"drugbank":["DB11221"],"chEBI":["34208"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL133463","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]1O","inchiKey":"UFZTZBNSLXELAL-IOSLPCCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26756672"],"drugbank":["DB03909"],"chEBI":["40532"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1373","canonicalSmiles":"NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1","inchiKey":"YFGHCGITMMYXAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MODAFINIL","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Modafinil","Provigil"],"synonyms":["CEP 1538","CEP-1538","CRC-40476","CRL 40476","CRL-40476","DEP-1538","Modafinil","Modafinil civ","Modaphonil","Modiodal","NSC-751178","NSC-759110","THN-102 COMPONENT MODAFINIL","THN102 COMPONENT MODAFINIL"],"crossReferences":{"DailyMed":["modafinil"],"PubChem":["144205023","170465042","26719679","26749058","26753746"],"Wikipedia":["Modafinil"],"drugbank":["DB00745"],"chEBI":["77585"]},"linkedTargets":{"rows":["ENSG00000142319"],"count":1},"linkedDiseases":{"rows":["MONDO_0021107","MONDO_0005090","EFO_0002610","MONDO_0002009","EFO_0000756","EFO_0005252","EFO_0003768","EFO_0008568","MONDO_0021063","EFO_0004698","HP_0100543","EFO_0000289","MONDO_0002050","MONDO_0021698","MONDO_0005180","EFO_0000712","EFO_0004701","HP_0012378","MONDO_0007079","HP_0002015","EFO_0003877","EFO_0002617","EFO_0003888","HP_0000360","MONDO_0008170","EFO_0001358","EFO_0003060","EFO_0003890","MONDO_0002491","MONDO_0005301","EFO_0000174","MONDO_0004975","EFO_0005611","EFO_0003918","EFO_0003833","EFO_0005411","MONDO_0005178","EFO_0007454"],"count":38},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for attention deficit hyperactivity disorder and has 32 investigational indications."}
{"id":"CHEMBL1453317","canonicalSmiles":"CCN(CC)C(=O)c1cccc(C)c1","inchiKey":"MMOXZBCLCQITDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLTOLUAMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["DEET","Deet","Deet n,n-diethyl-meta-toluamide","Diethyl toluamide","Diethyltoluamide","Diethyltoluamidum","ENT-20218","ENT-22542","N,n-diethyl 3-methyl benzamide","NSC-33840","Oristar deet"],"crossReferences":{"PubChem":["144204654","144209178","144211234","170466080","17389576","26747323","26752940","56320635"],"Wikipedia":["DEET"],"drugbank":["DB11282"],"chEBI":["7071"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for parasitic infection."}
{"id":"CHEMBL146","canonicalSmiles":"Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1","inchiKey":"NLZUEZXRPGMBCV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTYLATED HYDROXYTOLUENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,6-di-tert-butyl-p-cresol","2,6-ditertiary-butyl-p-cresol","BHT","Butylated hydroxytoluene","Butylated hydroxytoluene (e 321)","Butylhydroxytoluene","Butylhydroxytoluenum","E-321","E321","FEMA NO. 2184","INS NO.321","INS-321","Kerabit","NSC-6347"],"crossReferences":{"PubChem":["11532869","144207086","144208291","144213719","170466785","17390001","26753102"],"Wikipedia":["Butylated_hydroxytoluene"],"chEBI":["34247"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1627201","canonicalSmiles":"C[S@+]([O-])CCCCN=C=S","inchiKey":"SUVMJBTUFCVSAD-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-SULFORAPHANE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-sulforaphane"],"crossReferences":{"chEBI":["47809"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL165790","canonicalSmiles":"CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1","inchiKey":"SFBODOKJTYAUCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRIFLAVONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7-isopropoxyisoflavone","Ipriflavone","NSC-755888","Osten","Ostivone"],"crossReferences":{"PubChem":["124883354","144205085","144206723","170465997","170466811","174006866","26719630","29215021","56422482","856008"],"Wikipedia":["Ipriflavone"],"drugbank":["DB13618"],"chEBI":["31719"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL16645","canonicalSmiles":"Cc1ccc(O)cc1","inchiKey":"IWDCLRJOBJJRNH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"p-CRESOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Methylphenol","p-cresol","para-cresol"],"crossReferences":{"PubChem":["144206791","144206995","144207600","144208313","144210349","170465495","17389093","26747378"],"Wikipedia":["P-Cresol"],"drugbank":["DB01688"],"chEBI":["17847"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1680","canonicalSmiles":"C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O","inchiKey":"DEQANNDTNATYII-OULOTJBUSA-N","drugType":"Protein","blackBoxWarning":false,"name":"OCTREOTIDE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sandostatin"],"synonyms":["Octreotide","SMS 201-995","SMS-201-995","SMS-995","SMS995"],"crossReferences":{"DailyMed":["octreotide%20acetate"],"PubChem":["50126343"],"Wikipedia":["Octreotide"],"drugbank":["DB00104"]},"childChemblIds":["CHEMBL3545066","CHEMBL1200480","CHEMBL2105834"],"linkedTargets":{"rows":["ENSG00000162009","ENSG00000132671","ENSG00000278195","ENSG00000139874","ENSG00000180616"],"count":5},"linkedDiseases":{"rows":["EFO_0003086","HP_0002239","EFO_1001901","EFO_0000555","EFO_0000768","MONDO_0000540","EFO_0005252","MONDO_0007254","EFO_0009322","EFO_1002048","MONDO_0004565","MONDO_0005277","Orphanet_739","EFO_0000544","EFO_0000182","EFO_0002626","Orphanet_2495","EFO_1000045","EFO_0000616","MONDO_0000447","MONDO_0043579","EFO_0002618","MONDO_0021058","EFO_0001074","EFO_0007331","HP_0002014","MONDO_0024503","EFO_0000232","Orphanet_657","EFO_0003770","EFO_0004243","EFO_0001073","EFO_1001496","MONDO_0008315","EFO_0000311","EFO_0009708","MONDO_0002691","EFO_0001422","EFO_1000097","EFO_1000581","EFO_1001485","EFO_1000478","MONDO_0002120","Orphanet_774","EFO_0000574","EFO_0009545","EFO_1000852","MONDO_0024880","HP_0002019","MONDO_0017611"],"count":50},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and has 4 approved and 38 investigational indications."}
{"id":"CHEMBL1697742","canonicalSmiles":"O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"FZWBNHMXJMCXLU-BLAUPYHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTRAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dextran","Dextran 40","LMWD"],"crossReferences":{"chEBI":["27649"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1697763","canonicalSmiles":"O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1CO","inchiKey":"UIDWQGRXEVDFCA-XCVCLJGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIFURTOINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nifurtoinol","Urfadyn"],"crossReferences":{"drugbank":["DB13730"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1743027","drugType":"Antibody","blackBoxWarning":false,"name":"GIRENTUXIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Rencarex"],"synonyms":["CA9-SCAN CG250","CG-250","CG250","Girentuximab","WX-G250"],"linkedTargets":{"rows":["ENSG00000107159"],"count":1},"linkedDiseases":{"rows":["EFO_0000681","EFO_0000349","MONDO_0002367"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1743075","drugType":"Antibody","blackBoxWarning":false,"name":"TABALUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2127399","LY2127399","Tabalumab"],"linkedTargets":{"rows":["ENSG00000102524"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0002690","EFO_0003884","EFO_0003929","EFO_0001378"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1743261","canonicalSmiles":"CC1COC2(c3ccccc3Cl)c3cc(Cl)ccc3NC(=O)CN12","inchiKey":"ANUCDXCTICZJRH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEXAZOLAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CS-386","Melex","Mexazolam"],"crossReferences":{"PubChem":["170465840"],"drugbank":["DB15489"],"chEBI":["31842"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL177367","canonicalSmiles":"O=[N+]([O-])[O-].[Ag+]","inchiKey":"SQGYOTSLMSWVJD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SILVER NITRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Avoca","Caustic","Silver nit caustic"],"synonyms":["Argenti nitras","Argentum nitricum","NSC-135800","Silver Nitrate","Silver nitrate","Silver nitrate, toughened","Toughened silver nitrate"],"crossReferences":{"DrugCentral":["4502"],"Wikipedia":["Silver_nitrate"],"drugbank":["DB11080"],"chEBI":["32130"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1773903","canonicalSmiles":"CC(=O)O[C@H]1CC(C)(C)C(=C=C/C(C)=C/C=C/C(C)=C/C=C(C)/C=C/C=C(\\C)C(=O)C[C@@]23O[C@]2(C)C[C@@H](O)CC3(C)C)[C@](C)(O)C1","inchiKey":"MNUMHDZZMWCBBX-JWAQYZNWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FUCOXANTHIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["All-trans-fucoxanthin","CHEBI:5186","Fucoxanthin","Fucoxanthin, all-trans-","Sebatrol"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1897738","canonicalSmiles":"CCC(C)(Oc1ccc(C2(c3ccc(OC(C)(CC)C(=O)O)cc3)CCCCC2)cc1)C(=O)O","inchiKey":"BMOVQUBVGICXQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLINOFIBRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clinofibrate","Lipoclin"],"crossReferences":{"PubChem":["170465771","174007296","50112707"],"drugbank":["DB09006"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL195591","canonicalSmiles":"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.Cc1cc(CS(=O)(=O)c2ccc(N)cc2)no1","inchiKey":"CTNTUFQBOKZSPI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CO-TRIMOXAZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Co-trimoxazole","Cotrimoxazole"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1997373","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CC[Si](C)(C)C","inchiKey":"POADTFBBIXOWFJ-VWLOTQADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COSITECAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Karenitecin"],"synonyms":["BNP-1350","BNP1350","Cositecan","Karentecin"],"crossReferences":{"PubChem":["530668"],"drugbank":["DB05806"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2104788","canonicalSmiles":"O=C(O)c1ccccc1O.c1c[nH]cn1","inchiKey":"XCHHJFVNQPPLJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMIDAZOLE SALICYLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imidazole salicylate","Imidazole-2-hydroxybenzoate","Selezen"],"crossReferences":{"drugbank":["DB13860"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107214","canonicalSmiles":"CN(C(=O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I","inchiKey":"NJKDOADNQSYQEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOMEPROL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-7337","E7337","Iomeprol","Iomeron 300"],"crossReferences":{"PubChem":["144207160"],"drugbank":["DB11705"],"chEBI":["31710"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2107817","canonicalSmiles":"NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)[O-].[Na+]","inchiKey":"RTCIKUMODPANKX-JBUOLDKXSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"AVIBACTAM SODIUM","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1689063","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nxl-104"],"synonyms":["Avibactam sodium","Avibactam sodium salt","NXL104","Nxl 104"],"crossReferences":{"DailyMed":["avibactam%20sodium"],"chEBI":["85982"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 approved indications."}
{"id":"CHEMBL2108463","drugType":"Unknown","blackBoxWarning":false,"name":"GARLIC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ae-garlic","Allii bulbus","Allii sativi bulbus","Allium arenarium bulb","Allium controversum bulb","Allium longicuspis bulb","Allium ophioscorodon bulb","Allium pekinense bulb","Allium sativum","Allium sativum (garlic) bulb powder","Allium sativum bulb","Allium sativum bulb extract","Allium sativum bulb powder","Allium sativum extract","Allium sativum ophioscorodon","Allium sativum powder","Allium sativum whole","B1233","Cultivated garlic whole","Dasuan","Garlic","Garlic bulb","Garlic powder","Garlic root","Garlic, raw","Garlic,raw","Porrum ophioscorodon bulb","Porrum sativum bulb","Serpent garlic","Spices, garlic powder"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2108751","drugType":"Unknown","blackBoxWarning":false,"name":"PECTIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Apple pectin","Citrus pectin","E-440","INS NO.440","INS-440","Pectin","Pectin, apple","Pectin, citrus","Pectins"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2108757","drugType":"Protein","blackBoxWarning":false,"name":"PENTETREOTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-pentetoreotide","DTPA-SMS","Pentetoreotide","Pentetreotide","SDZ 215-811","SDZ 215-811S","SDZ-215-811","SDZ-215-811S","SDZ-215811"],"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108975","drugType":"Protein","blackBoxWarning":false,"name":"ANCESTIM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amj-9302","Ancestim","Ancestim (genetical recombination)","N-l-methionyl-1-165-c-kit ligand","N-l-methionyl-1-165-mgf","N-l-methionyl-1-165-scf","Stem cell factor ancestim","Stemgen"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109009","drugType":"Unknown","blackBoxWarning":false,"name":"CELLULOSE, MICROCRYSTALLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Avicel ph"],"synonyms":["Cellulose, crystalline","Cellulose, dispersible","Cellulose, microcrystalline","Crystalline cellulose","Dispersible cellulose","E460","Microcrystalline cellulose"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109204","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"NADROPARIN CALCIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CY 216","CY-216","Fraxiparin","Fraxiparina","Fraxiparine","Nadroparin","Nadroparin calcium","Seleparina","Ultraparina"],"crossReferences":{"DrugCentral":["5162"]},"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109500","drugType":"Antibody","blackBoxWarning":false,"name":"LIRILUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-KIR Antibody","BMS-986015","BMS-986015-01","BMS-98601501","IPH-2102","IPH2102","Lirilumab"],"linkedTargets":{"rows":["ENSG00000125498","ENSG00000276011","ENSG00000243772"],"count":3},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000616","EFO_0000095","EFO_0000222","EFO_0001378","EFO_0000183","EFO_0005952","EFO_0000181","EFO_0000311","MONDO_0001187"],"count":10},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL2109509","drugType":"Antibody","blackBoxWarning":false,"name":"HCBE-11","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HCBE-11","Hcbe-11"],"linkedTargets":{"rows":["ENSG00000111321"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109531","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-6469","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9b12, a murine igg1 antibody","MEDI-6469","MEDI6469","Medi-6469"],"linkedTargets":{"rows":["ENSG00000186827"],"count":1},"linkedDiseases":{"rows":["EFO_0006859","MONDO_0007254","EFO_0000574","EFO_0004142","EFO_0000196","EFO_0002617"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2110557","canonicalSmiles":"[Cl-].[Rb+]","inchiKey":"FGDZQCVHDSGLHJ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"RUBIDIUM CHLORIDE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["rubidium%20chloride%20rb-82"],"chEBI":["78672"]},"childChemblIds":["CHEMBL1200727"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989 and is indicated for coronary artery disease. This drug has a black box warning from the FDA."}
{"id":"CHEMBL227745","canonicalSmiles":"CC(=O)c1cc(F)c(Cl)cc1NCC(=O)Nc1ccccc1C(=O)O","inchiKey":"LBMZLHCAPBBOFS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL227745","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07085"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2336050","canonicalSmiles":"CCCCCCOc1nsnc1C1=CCCN(C)C1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"SJSVWTMVMBGIHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XANOMELINE TARTRATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL21536","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-246708 TARTRATE","LY246708 TARTRATE","Xanomeline Tartaric Acid","Xanomeline tartrate"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2364574","canonicalSmiles":"C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.[Ca+2]","inchiKey":"GJPGCACMCURAKH-YQCFNCLSSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXYCYCLINE CALCIUM","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1433","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vibramycin"],"synonyms":["Doxycycline calcium"],"linkedTargets":{"rows":["ENSG00000137745","ENSG00000196611","ENSG00000118113","ENSG00000137673"],"count":4},"linkedDiseases":{"rows":["EFO_0003102"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974 and has 1 investigational indication."}
{"id":"CHEMBL2364605","canonicalSmiles":"CN(C)[C@]1(c2ccccc2)CC[C@]2(CC1)OCCc1c3cc(F)ccc3[nH]c12","inchiKey":"CSMVOZKEWSOFER-RQNOJGIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEBRANOPADOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cebranopadol","GRT-6005","GRT6005"],"crossReferences":{"drugbank":["DB12830"]},"childChemblIds":["CHEMBL3325957"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000125510","ENSG00000112038"],"count":4},"linkedDiseases":{"rows":["MONDO_0001583","EFO_0003890","EFO_0004616","HP_0003419","EFO_0003843"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL250450","canonicalSmiles":"O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12","inchiKey":"OVSQVDMCBVZWGM-QSOFNFLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOQUERCETIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-glucosylquercetin","Contigoside b","FEMA NO. 4225","Glucosyl-3-quercetin","Hirsutrin","Isoquercetin","Isoquercetin, (-)-","Isoquercitrin","Isoquercitroside","Isotrifoliin","Isotrifolin","NSC-115918","NSC-407304","Quercetin 3-d-glucoside","Quercetin 3-o-glucopyranoside","Quercetin 3-o-glucoside","Quercetin 3.beta.-glucoside","Quercetin glucoside","Quercetin-3-glucose","Quercetin-3-o-glucoside","Quercetol 3-monoglucoside","Ronacare isoquercetin"],"crossReferences":{"PubChem":["26719900","49681636"],"drugbank":["DB12665"],"chEBI":["68352"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL26","canonicalSmiles":"CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC","inchiKey":"BGRJTUBHPOOWDU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULPIRIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dogmatyl","Dolmatil"],"synonyms":["N05AL01","NSC-757850","RD-1403","Sulpiride"],"crossReferences":{"PubChem":["144212522","50104625"],"TG-GATEs":["115"],"Wikipedia":["Sulpiride"],"drugbank":["DB00391"],"chEBI":["32168"]},"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002050","HP_0000726","EFO_0005407","EFO_0005230","EFO_0005411"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for psychosis and has 4 investigational indications."}
{"id":"CHEMBL269634","canonicalSmiles":"C[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)O","inchiKey":"FAKRSMQSSFJEIM-BQBZGAKWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL269634","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02032"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL279676","canonicalSmiles":"c1csc(C2(N3CCCCC3)CCCCC2)c1","inchiKey":"JUZZEWSCNBCFRL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENOCYCLIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tenocyclidine","Thienylcyclidine","Thienylphencyclidine"],"crossReferences":{"PubChem":["144205386","29216149"],"Wikipedia":["Tenocyclidine"],"drugbank":["DB01520"],"chEBI":["64610"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL280487","canonicalSmiles":"C=C1[C@@H]([C@@H](O)C[C@H](C)[C@H]2O[C@@]3(CCCCO3)CC[C@H]2C)O[C@@H]2CC[C@@]3(CC[C@H](/C=C/[C@@H](C)[C@@H]4CC(C)=C[C@@]5(O[C@H](C[C@@](C)(O)C(=O)O)CC[C@H]5O)O4)O3)O[C@H]2[C@@H]1O","inchiKey":"QNDVLZJODHBUFM-WFXQOWMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OKADAIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Okadaic_acid"],"drugbank":["DB02169"],"chEBI":["44658"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL283639","canonicalSmiles":"Cc1cc(CCCCCCCOc2ccc(C3=NCCO3)cc2)on1","inchiKey":"FKLJPTJMIBLJAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DISOXARIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Disoxaril","WIN 51,711","WIN-51711"],"crossReferences":{"drugbank":["DB08726"],"chEBI":["3846"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL284483","canonicalSmiles":"OC[C@H]1O[C@@H](n2cnc3c2N=CNC[C@H]3O)[C@H](O)[C@@H]1O","inchiKey":"YOOVTUPUBVHMPG-LODYRLCVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COFORMYCIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Coformycin","NSC-277817"],"crossReferences":{"chEBI":["16213"]},"linkedTargets":{"rows":["ENSG00000196839"],"count":1},"linkedDiseases":{"rows":["EFO_0000565"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL305785","canonicalSmiles":"O=C(O)C(=O)N(c1ccccc1C(=O)O)c1cccc2ccc(O)cc12","inchiKey":"IGOULVZYQKJJKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL305785","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07295"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3128043","canonicalSmiles":"Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1","inchiKey":"AYCPARAPKDAOEN-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-03758309","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-03758309","PF-3758309","Pf-03758309"],"crossReferences":{"drugbank":["DB11775"]},"linkedTargets":{"rows":["ENSG00000130669"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL325424","canonicalSmiles":"Cc1cccc(-c2ccc3c(c2)c(C(=O)C(=O)O)cn3Cc2ccc(C(C)(C)C)cc2)c1","inchiKey":"HSXLMAFNWCSZGP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALEPLASININ","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aleplasinin","PAZ-417"],"crossReferences":{"drugbank":["DB12635"]},"linkedTargets":{"rows":["ENSG00000106366"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3301583","drugType":"Unknown","blackBoxWarning":false,"name":"ANDEXANET ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Andexanet alfa","Andexxa","PRT-064445","PRT-4445","PRT064445","rfXa Inhibitor Antidote"],"linkedTargets":{"rows":["ENSG00000003436"],"count":1},"linkedDiseases":{"rows":["MP_0001914","EFO_0000551"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3408248","canonicalSmiles":"C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12","inchiKey":"LMJFJIDLEAWOQJ-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3408248","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15029"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3410450","canonicalSmiles":"Cc1cn2nc([C@@H]3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)cc2nc1N1CC[C@H](N)C1","inchiKey":"GOFXWTVKPWJNGD-UWJYYQICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRESATOVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-5806","Presatovir"],"crossReferences":{"drugbank":["DB12165"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545017","canonicalSmiles":"O=C(c1ccc(O)c(F)c1)N(c1ccc(O)cc1)c1ccc(F)cc1","inchiKey":"FBCQEUMZZNVQKD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GTX-758","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Capesaris"],"synonyms":["Gtx 758","Gtx-758"],"crossReferences":{"drugbank":["DB14969"]},"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MONDO_0008315"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545245","drugType":"Small molecule","blackBoxWarning":false,"name":"BAY-1082439","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bay-1082439"],"linkedTargets":{"rows":["ENSG00000051382","ENSG00000121879"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3638051","canonicalSmiles":"COc1ccc(S(=O)(=O)NCc2cc(CN3CCCC3)c(O)c(CN3CCCC3)c2)cc1","inchiKey":"SYZGIWXQGIBJGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULCARDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4594410"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3646221","canonicalSmiles":"O=C(O)CNC(=O)c1ncc(-c2cccc(Cl)c2)cc1O","inchiKey":"JGRXMPYUTJLTKT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VADADUSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AKB-6548","B-506","B506","PG-1016548","PG1016548","Vadadustat"],"crossReferences":{"drugbank":["DB12255"]},"linkedTargets":{"rows":["ENSG00000135766","ENSG00000129521","ENSG00000269858"],"count":3},"linkedDiseases":{"rows":["EFO_0003884","EFO_0001421","EFO_0004272"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL364748","canonicalSmiles":"O=C(O)[C@H](Cc1ccccc1)Oc1ccc(Cl)cc1","inchiKey":"CPBLTMSKPQDJPW-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL364748","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08760"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707311","canonicalSmiles":"CCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@@]21C","inchiKey":"AJAMXPWEAPICIM-XCAPYKEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VAMOROLONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9,11-dehydro dexamethasone","VBP-15","Vamorolone","Vamorolone acetate","Vbp-15 free alcohol"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL372164","canonicalSmiles":"CS(=O)(=O)N1CCC([C@H]2c3ccc(Cl)cc3C(N3CCNCC3)=Cc3cccnc32)CC1","inchiKey":"ZMGCFGGMTCMSDP-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL372164","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07216"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL372795","canonicalSmiles":"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O","inchiKey":"UCSJYZPVAKXKNQ-HZYVHMACSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"STREPTOMYCIN","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chemform","Gerox","NSC-14083","Strepcen","Streptomycin"],"crossReferences":{"drugbank":["DB01082"],"chEBI":["17076"]},"childChemblIds":["CHEMBL3184791","CHEMBL453087"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1946 and has 8 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL373466","canonicalSmiles":"C[C@@H](Cl)CCl","inchiKey":"KNKRKFALVUDBJE-GSVOUGTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R)-1,2-Dichloropropane","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(R)-1,2-Dichloropropane"],"crossReferences":{"drugbank":["DB01701"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833367","drugType":"Small molecule","blackBoxWarning":false,"name":"SATRAPLATIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-182751","BMY-45594","JM-216","NSC-744226","Satraplatin"],"crossReferences":{"DrugCentral":["4703"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3976807","canonicalSmiles":"Cc1cc(N2C(=O)NC(=O)C2(C)C)cc(C)c1CCS(=O)(=O)N1CCC2(CC1)N=C(c1ccc(OC(F)(F)F)cc1)NC2=O","inchiKey":"LDZJFVOUPUFOHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PCO-371","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PCO371","Pc-0371","Pco-371","Pco371"],"crossReferences":{"drugbank":["DB14946"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989514","canonicalSmiles":"CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC.Cl.O.O.O","inchiKey":"KLEAIHJJLUAXIQ-JDRGBKBRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IRINOTECAN HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL481","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Campto","Camptosar","Irinotecan hydrochloride","Onivyde"],"synonyms":["CPT-11","DQ-2805","Irinotecan hydrochloride","Irinotecan hydrochloride anhydrous","Irinotecan hydrochloride hydrate","Irinotecan hydrochloride trihydrate","Irinotecan monohydrochloride trihydrate","NSC-759878","U-101,440E","U-101440E"],"crossReferences":{"DailyMed":["irinotecan%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000198900"],"count":1},"linkedDiseases":{"rows":["EFO_1000419","EFO_0000637","EFO_0000365","EFO_0000681","EFO_0000632","EFO_1001951","EFO_0000178","MONDO_0002974","MONDO_0021633","MONDO_0008903","EFO_1000251","EFO_1000532","EFO_0002918","EFO_0002618","MONDO_0002537","MONDO_0019465","MONDO_0018271","EFO_1001512","MONDO_0008315","MONDO_0001879","Orphanet_398934","MONDO_0002691","EFO_1001365","EFO_0003032","EFO_0000574","EFO_1000550","EFO_1001465","MONDO_0007254","EFO_0000255","EFO_0001071","MONDO_0044937","MONDO_0020654","MONDO_0001056","MONDO_0002158","MONDO_0003165","EFO_0002499","EFO_0000183","EFO_0004193","EFO_0000707","EFO_0005588","EFO_0000616","EFO_0006859","EFO_0000403","Orphanet_44890","EFO_1001042","MONDO_0007576","EFO_0007535","EFO_1001471","MONDO_0002120","EFO_0002517","EFO_0000702","MONDO_0002367","MONDO_0018906","MONDO_0024880","EFO_0000519","MONDO_0044926","MONDO_0003060","MONDO_0000873","MONDO_0016167","EFO_0001075","MONDO_0000956","MONDO_0045056","EFO_1000657","EFO_0000228","EFO_0000565","EFO_0000309","EFO_0006732","EFO_0000389","MONDO_0005411","MONDO_0020634","EFO_1000785","EFO_0000364","MONDO_0003000","MONDO_0001852","EFO_1000606","EFO_1000292","MONDO_0021321","EFO_0000248","MONDO_0008170","MONDO_0004669","EFO_0002939","EFO_0000502","EFO_1000407","MONDO_0044787","EFO_0005537","EFO_1001051","MONDO_0019471","EFO_0002938","MONDO_0044964","MONDO_0100342","MONDO_0015686","MONDO_0004192","MONDO_0044887","MONDO_0003196","EFO_1000475","EFO_1001469","MONDO_0021063","MONDO_0002087","EFO_0000305","MONDO_0001187","EFO_1001480","EFO_1000044","EFO_1001013","MONDO_0001475","EFO_0006352","EFO_0002617","EFO_1000158","EFO_0000437","EFO_0000503","EFO_0000313","EFO_0002501","MONDO_0016717","EFO_0004243","MONDO_0021038","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0000095","EFO_0000174","EFO_0004142","MONDO_0001325","EFO_0000691"],"count":122},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for carcinoma and adenocarcinoma and has 97 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3990003","drugType":"Cell","blackBoxWarning":false,"name":"BALTALEUCEL-T","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Baltaleucel","Baltaleucel-t","CMD-003"],"description":"Cell drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3990047","canonicalSmiles":"CNc1ncc(-c2ccc3c(=O)c(C(=O)O)cn(C4CC4)c3c2C)cc1C","inchiKey":"XPIJWUTXQAGSLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OZENOXACIN","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xepi"],"synonyms":["GF-001001-00","Gf-001001-00","Ozenoxacin","T-3912"],"crossReferences":{"DailyMed":["ozenoxacin"],"drugbank":["DB12924"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for impetigo and has 1 investigational indication."}
{"id":"CHEMBL416898","canonicalSmiles":"Clc1ccc(C(c2ccc(Cl)cc2)C(Cl)(Cl)Cl)cc1","inchiKey":"YVGGHNCTFXOJCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROPHENOTHANE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["4,4'-ddt","Chlorophenothane","Chlorphenotane","Clofenotane","Ddt","Ddt, p,p'-","Dicophane","ENT-1506","NSC-8939","P,p'-ddt","Penticide"],"crossReferences":{"PubChem":["144204627","144208693","144210387","170465529","17389946","26747293","26752896"],"Wikipedia":["DDT"],"drugbank":["DB13424"],"chEBI":["16130"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for parasitic infection."}
{"id":"CHEMBL422","canonicalSmiles":"CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1","inchiKey":"ZEWQUBUPAILYHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRIFLUOPERAZINE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amylozine","Stelazine","Stelazine fte"],"synonyms":["Apo-trifluoperazine","Flurazine","NSC-17474","NSC-46061","RP-7623","Trifluoperazine"],"crossReferences":{"DailyMed":["trifluoperazine%20hydrochloride"],"PubChem":["11110644","11110645","124877144","124877145","174006276","26751598","26751599","4252673","50100152","50104251","50104252","50104253","57287812","90341087","92763314"],"Wikipedia":["Trifluoperazine"],"drugbank":["DB00831"],"chEBI":["45951"]},"childChemblIds":["CHEMBL1726794","CHEMBL1257040","CHEMBL1710"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000069696","ENSG00000102468","ENSG00000151577","ENSG00000147246"],"count":5},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0006788","EFO_0000677","EFO_0005407"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 4 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4292264","canonicalSmiles":"CC1(C)CCC2(CC1)N[C@@H](C(=O)N[C@@H]1CC[C@@H](C(N)=O)OC1)[C@H](c1ccnc(Cl)c1F)[C@]21C(=O)Nc2cc(Cl)ccc21","inchiKey":"RYAYYVTWKAOAJF-QISPRATLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MILADEMETAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DS-3032","Ds-3032","Mdm2 inhibitor ds-3032","Milademetan"],"crossReferences":{"drugbank":["DB15257"]},"childChemblIds":["CHEMBL4297374"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297147","canonicalSmiles":"CC(O)C(=O)O.O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1","inchiKey":"BVUSNQJCSYDJJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"HALOPERIDOL LACTATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL54","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Haldol","Haloperidol intensol","Haloperidol lactate"],"synonyms":["Haloperidol lactate"],"crossReferences":{"DailyMed":["haloperidol%20lactate"]},"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000102468","ENSG00000151577"],"count":4},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0005411","HP_0000713"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for schizophrenia and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297204","canonicalSmiles":"NCCC[C@H](N)C(=O)O.O=C(O)Cc1ccccc1","inchiKey":"LRSYFEZBIMVWRY-VWMHFEHESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORNITHINE PHENYLACETATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL446143","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-OP","OCR-002","OP","Ocr-002","Ornithine phenylacetate"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297310","canonicalSmiles":"Cc1ccccc1CN1C(=O)C2=C(CCN(Cc3ccccc3)C2)N2CCN=C12","inchiKey":"VLULRUCCHYVXOH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ONC-201","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-350625","ONC201","Onc 201","Onc-201","Onc201","TIC-10","TIC10"],"crossReferences":{"drugbank":["DB14844"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL4297420","canonicalSmiles":"[223Ra]","inchiKey":"HCWPIIXVSYCSAN-OIOBTWANSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RADIUM RA-223","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4300465","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Radium ra-223","Radium-223"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297621","canonicalSmiles":"C[C@@H](N[C@H]1CCN(c2ccc(CC(=O)O)cc2)C1)c1cccc2ccccc12","inchiKey":"RZNUIYPHQFXBAN-XLIONFOSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EVOCALCET","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Evocalcet","KHK-7580","KHK7580","Khk7580","MT-4580"],"crossReferences":{"drugbank":["DB12388"]},"childChemblIds":["CHEMBL4128835"],"linkedTargets":{"rows":["ENSG00000036828"],"count":1},"linkedDiseases":{"rows":["EFO_1001173","EFO_0008506"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297644","canonicalSmiles":"Cc1n[nH]cc1-c1cc2nc([C@@H]3CC4CCN3CC4)[nH]c(=O)c2s1","inchiKey":"XGVXKJKTISMIOW-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMUROSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Simurosertib","TAK-931","TAK931F","Tak 931","Tak-931"],"linkedTargets":{"rows":["ENSG00000097046"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297649","canonicalSmiles":"CC(C)COc1cc(F)cc(-c2ccc(C(=O)NS(=O)(=O)c3ccccc3)c(N3C[C@@H](C)CC3(C)C)n2)c1","inchiKey":"NHOUNZMCSIHKHJ-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLACAFTOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Olacaftor","VX-440","Vx-440"],"linkedTargets":{"rows":["ENSG00000001626"],"count":1},"linkedDiseases":{"rows":["Orphanet_586"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297812","drugType":"Unknown","blackBoxWarning":false,"name":"PREP-001","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jnj-43260295","Poly i:poly c","Poly-inosine:poly-cytosine","Prep-001"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297822","drugType":"Unknown","blackBoxWarning":false,"name":"SAN-300","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-vla-1 antibody - salix","San-300"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297954","drugType":"Unknown","blackBoxWarning":false,"name":"FIBROBLAST GROWTH FACTOR-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acidic fibroblast growth factor","Endothelial cell growth factor","Fgf-1","Fibroblast growth factor 1","Fibroblast growth factor-1","Hbgf-1","Heparin-binding growth factor 1","Human fibroblast growth factor 1","Human oligopeptide-13","Nexpure bio afgf","Rh-polypeptide-11","Sh-polypeptide-11","Vexxon-afgf"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297966","drugType":"Antibody","blackBoxWarning":false,"name":"DEZAMIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti - sap mab","Dezamizumab","GSK-2398852","GSK2398852","Gsk2398852","anti-SAP mAb"],"linkedTargets":{"rows":["ENSG00000132703"],"count":1},"linkedDiseases":{"rows":["EFO_1001875","Orphanet_314701"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL439849","canonicalSmiles":"N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1","inchiKey":"SGEGOXDYSFKCPT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VILAZODONE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["EMD 515259","EMD-515259","EMD-68-843","Vilazodone"],"crossReferences":{"DailyMed":["vilazodone%20hydrochloride"],"Wikipedia":["Vilazodone"],"drugbank":["DB06684"],"chEBI":["70707"]},"childChemblIds":["CHEMBL1615374"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000178394"],"count":2},"linkedDiseases":{"rows":["EFO_0007191","EFO_0001072","EFO_1001892","MONDO_0002050","MONDO_0002009","EFO_0003761","EFO_0001358","EFO_1001916"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for unipolar depression and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL440","canonicalSmiles":"C=CCC1(C(C)CCC)C(=O)N=C(S)NC1=O","inchiKey":"XLOMZPUITCYLMJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAMYLAL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-120815","Thiamylal"],"crossReferences":{"Wikipedia":["Thiamylal"],"drugbank":["DB01154"],"chEBI":["9536"]},"childChemblIds":["CHEMBL1201065"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL443114","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@H](O[C@H]3CC[C@@]4(C)C(=CC[C@H]5[C@@H]6C[C@@H]7O[C@]8(CC[C@@H](C)CN8)[C@@H](C)[C@@H]7[C@@]6(C)CC[C@@H]54)C3)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"MBWUSSKCCUMJHO-ZGXDEBHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOLAMARGINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Solamargine"],"crossReferences":{"Wikipedia":["Solamargine"],"drugbank":["DB12700"],"chEBI":["9185"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4446378","canonicalSmiles":"CO[C@H]1/C=C/C[C@H](C)[C@@H](C)S(=O)(=O)NC(=O)c2ccc3c(c2)N(C[C@@H]2CC[C@H]21)C[C@@]1(CCCc2cc(Cl)ccc21)CO3","inchiKey":"JQNINBDKGLWYMU-GEAQBIRJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAPOTOCLAX","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 176","AMG-176","AMG176","Amg 176","Mcl-1 inhibitor amg 176","Mcl-1 inhibitor amg-176","Tapotoclax"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594250","canonicalSmiles":"Cc1ccc(C(=O)OCc2ccc([C@@H](CN)C(=O)Nc3ccc4cnccc4c3)cc2)c(C)c1","inchiKey":"OURRXQUGYQRVML-AREMUKBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NETARSUDIL","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AR-11324 FREE BASE","AR-13324","Netarsudil"],"crossReferences":{"DailyMed":["netarsudil%20dimesylate","netarsudil%20mesylate"]},"childChemblIds":["CHEMBL4594251","CHEMBL4796289"],"linkedTargets":{"rows":["ENSG00000134318","ENSG00000067900"],"count":2},"linkedDiseases":{"rows":["Orphanet_98974","EFO_0004190","EFO_1001069","EFO_1001022","EFO_1000879","EFO_0000516"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL4594262","canonicalSmiles":"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl.O=C(O)c1ccccc1","inchiKey":"RVPCEXXEUXIPEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMLODIPINE BENZOATE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1491","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Katerzia"],"synonyms":["Amlodipine benzoate"],"crossReferences":{"DailyMed":["amlodipine%20benzoate"]},"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_0003144","EFO_0000712","EFO_0001645","EFO_0000612","EFO_0000400","EFO_0000537"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 6 approved indications."}
{"id":"CHEMBL4594558","drugType":"Antibody","blackBoxWarning":false,"name":"RAGIFILIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGEN-1876","AGEN1876","CM-701","CM701","INCAGN-01876","INCAGN01876","Incagn01876","Ragifilimab"],"linkedTargets":{"rows":["ENSG00000186891"],"count":1},"linkedDiseases":{"rows":["EFO_0006859","EFO_0000707","MONDO_0024880","EFO_0000519"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL463","canonicalSmiles":"Nc1ccc(C(=O)NCC(=O)O)cc1","inchiKey":"HSMNQINEKMPTIC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOHIPPURIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aminohippuric Acid","Aminohippuric acid","Aminohippuric acid, p-","NSC-13064","P-aminohippuric acid","Paha","Para-aminohippurate","Para-aminohippuric acid"],"crossReferences":{"PubChem":["11112164","124882008","144203896","170465155","26748682","56463545"],"Wikipedia":["Aminohippuric_acid"],"drugbank":["DB00345"],"chEBI":["104011"]},"childChemblIds":["CHEMBL1200365"],"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL4650283","canonicalSmiles":"CCCNc1nc(Nc2ccc(C#N)cc2)ncc1C#CCCCNC(=O)[C@H](C)N(C)C(=O)/C=C/CN(C)C","inchiKey":"HJFSVYUFOXAVAA-YUAYGMJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FF-10101","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FF-10101","FLT3-IN-1","Ff-10101","Ff-10101-01"],"linkedTargets":{"rows":["ENSG00000122025"],"count":1},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650289","drugType":"Unknown","blackBoxWarning":false,"name":"KBP5209","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KBP5209","Kbp-5209","Kbp5209"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000065361","ENSG00000178568","ENSG00000141736"],"count":4},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650474","drugType":"Protein","blackBoxWarning":false,"name":"INTERFERON ALFA-2B KINOID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ifn-k","Interferon alfa-2b kinoid","Interferon.alpha.kinoid"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL466269","canonicalSmiles":"CC(=O)N1c2cccc(O)c2NC2=C(C(=O)CC(C)(C)C2)[C@@H]1c1ccc(Cl)cc1Cl","inchiKey":"JJTPPGUNMJMPLY-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL466269","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08747"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL467058","canonicalSmiles":"CCCCCCCC(=O)OC[C@@H](O)[C@@H](OC)[C@@H]1OC(C(=O)O)=C[C@H](NC(=N)N)[C@H]1NC(C)=O","inchiKey":"UKTIJASCFRNWCB-RMIBSVFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANINAMIVIR OCTANOATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CS-8958","Laninamivir octanoate","Laninamivir octanoic acid ester","R-118958"],"crossReferences":{"drugbank":["DB11888"]},"childChemblIds":["CHEMBL2093880"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL48449","canonicalSmiles":"C[C@]12C(=O)OC(=O)[C@@]1(C)[C@@H]1CC[C@H]2O1","inchiKey":"DHZBEENLJMYSHQ-XCVPVQRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANTHARIDIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cantaridina","Cantharides camphor","Cantharidin","Cantharidine","Cantharidinum","NSC-61805"],"crossReferences":{"PubChem":["109184","11112131"],"Wikipedia":["Cantharidin"],"drugbank":["DB12328"],"chEBI":["64213"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL490","canonicalSmiles":"Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1","inchiKey":"AHOUBRCZNHFOSL-YOEHRIQHSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PAROXETINE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Paxil [as hydrochloride]"],"synonyms":["(-)3s,4r-paroxetine","Arketis","Arotin","BRL 29060","BRL-29060","Besitram","Casbol","Daparox","Fg-7051","Frosinor","Motivan","Parogen","Paroxetine","Paxil","Paxpar","Pexeva","Xetanor"],"crossReferences":{"DailyMed":["paroxetine%20hydrochloride","paroxetine%20mesylate"],"PubChem":["144206674","170465075","26752262","29215051","50104978","50104979","50104980","50104981","90341371"],"Wikipedia":["Paroxetine"],"drugbank":["DB00715"],"chEBI":["7936"]},"childChemblIds":["CHEMBL1449490","CHEMBL1708","CHEMBL1200609","CHEMBL1256912","CHEMBL3133300","CHEMBL1628650"],"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["EFO_0004320","MONDO_0005090","EFO_0005687","EFO_0004262","MONDO_0002009","EFO_0000555","HP_0000726","EFO_0000768","EFO_1001917","HP_0031217","EFO_0000289","MONDO_0002050","MONDO_0005180","EFO_0003761","EFO_0004242","MONDO_0007079","EFO_0005230","EFO_1001872","EFO_0005762","EFO_0000685","HP_0000360","EFO_0006788","EFO_0001645","EFO_1001908","EFO_0000677","EFO_0001358","MONDO_0002775","EFO_1001892","EFO_0004220","EFO_0007948","EFO_0000612","EFO_0003918","EFO_0003922"],"count":33},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 9 approved and 25 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL5","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21","inchiKey":"MHWLWQUZZRMNGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALIDIXIC ACID","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mictral","Nalidixic acid","Nalix","Neg Gram","Neggram","Negram","Uriben","Uroneg","Wintomylon"],"synonyms":["NSC-82174","Nalidixane","Nalidixate","Nalidixic acid","WIN 18,320","WIN-18320"],"crossReferences":{"PubChem":["120913","124883418","144204386","144208675","144213071","170465215","17389812","174006246","26746931","26751459","26751460","56422386","855620","90340622"],"Wikipedia":["Nalidixic_acid"],"drugbank":["DB00779"],"chEBI":["100147"]},"childChemblIds":["CHEMBL1741367","CHEMBL1255939"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL508461","canonicalSmiles":"O=C(O)C[C@@H](NC(=O)c1cc(-c2ccc(-c3ccncc3)cc2)cs1)c1ccccc1","inchiKey":"VMTJQZUZINLEKC-JOCHJYFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL508461","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03367"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL512351","canonicalSmiles":"COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1","inchiKey":"XHOLNRLADUSQLD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BETRIXABAN","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bevyxxa"],"synonyms":["Betrixaban","Betrixaban maleate","PRT-054021","PRT054021"],"crossReferences":{"Wikipedia":["Betrixaban"],"drugbank":["DB12364"]},"linkedTargets":{"rows":["ENSG00000126218"],"count":1},"linkedDiseases":{"rows":["HP_0001907","EFO_0003911","MP_0001914","EFO_0003086","EFO_0000275","EFO_0001421","EFO_0004286","HP_0004419"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for venous thromboembolism and recurrent thrombophlebitis and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL532","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O","inchiKey":"ULGZDMOVFRHVEP-RWJQBGPGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERYTHROMYCIN","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["A/t/s","Akne-mycin","Aknemycin plus","C-solve-2","E-base","E-glades","E-mycin","E-solve 2","Emgel","Ery-tab","Eryacne 2","Eryacne 4","Eryc","Eryc 125","Eryc sprinkles","Erycette","Eryderm","Erygel","Erymax","Erymax sprinkle","Erythra-derm","Erythro 200","Erythro-statin","Erythrocin","Erythromycin","Gallimycin","Ilotycin","Isotrexin","Kerymax","Oftalmolosa cusi eritromicina","Paediathrocin","R-p mycin","Retcin","Robimycin","Rommix 250 ec","Rommix 500 ec","Sansac","Staticin","Stiemycin","T-stat","Tiloryth","Wyamycin","Zineryt"],"synonyms":["Benzamycin","Bristamycin","E-Base","E-Glades","E-Mycin","ERY-TAB","Erypar","Erythro-Statin","Erythrocin","Erythromycin","Erythromycin estolate impurity, free erythromycin-","J01FA01","NSC-55929","PCE","Pfizer-E"],"crossReferences":{"DailyMed":["erythromycin","erythromycin%20stearate"],"DrugCentral":["3875"],"PubChem":["144204864","144205422","144210833","49675035"],"Wikipedia":["Erythromycin"],"drugbank":["DB00199"],"chEBI":["42355"]},"childChemblIds":["CHEMBL1200506","CHEMBL1200476","CHEMBL1200510","CHEMBL3545060","CHEMBL3786307"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 3 approved and 18 investigational indications."}
{"id":"CHEMBL539640","canonicalSmiles":"NCc1ccc(-c2cccs2)cc1","inchiKey":"YKNLMMDEWQZCLJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL539640","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07259"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL539906","canonicalSmiles":"O=c1[nH]cnc2sc3c(c12)CCCC3","inchiKey":"NMMOEJUJKIXUQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL539906","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["4255332"],"drugbank":["DB08777"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL560511","canonicalSmiles":"CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5","inchiKey":"RMRJXGBAOAMLHD-IHFGGWKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Buprenorphine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Buprenorphine"],"crossReferences":{"drugbank":["DB00921"],"chEBI":["3216"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL563377","canonicalSmiles":"COc1ccc(/N=c2/[nH]c(N)c(C(=O)c3ccc(OC)cc3)s2)cc1","inchiKey":"XQKUGFIWKSKCDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL563377","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["49668017","530855"],"drugbank":["DB07488"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL574060","canonicalSmiles":"O=C1c2c(O)cccc2C(=O)c2c([N+](=O)[O-])ccc(O)c21","inchiKey":"RIYCICFDXLNQPV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL574060","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03035"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL602070","canonicalSmiles":"CC1=C(C(=O)N2CCC[C@H]2c2ccc(F)cc2)[C@@H](c2ccc(Cl)c(Cl)c2)n2nccc2N1","inchiKey":"LADJRPDOKVCQCG-NZQKXSOJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-394136","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-394136"],"crossReferences":{"drugbank":["DB12067"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL607710","canonicalSmiles":"NC(=O)OCC(O)COc1ccc(Cl)cc1","inchiKey":"SKPLBLUECSEIFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPHENESIN CARBAMATE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Maolate"],"synonyms":["Chlorphenesin","Chlorphenesin carbamate","NSC-6401","NSC-82943","U-19,646","U-19646"],"crossReferences":{"PubChem":["144204038","56463366"],"Wikipedia":["Chlorphenesin"],"drugbank":["DB14656"],"chEBI":["3643"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1965."}
{"id":"CHEMBL786","canonicalSmiles":"CC/C(=C(\\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"FQZYTYWMLGAPFJ-OQKDUQJOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TAMOXIFEN CITRATE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL83","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emblon","Fentamox 10","Fentamox 20","Kentadex","Kessar","Kessar 10","Kessar 20","Noltam","Nolvadex","Nolvadex d","Nolvadex fte","Oestrifen-10","Oestrifen-20","Oestrifen-40","Soltamox","Tamofen","Tamoxifen citrate","Zynoplex"],"synonyms":["I.C.I.46474 CITRATE","ICI 46,474","ICI-46474","Kessar","NSC-180973","NSC-757345","Nourytam","Tamofene","Tamoxifen citrate","Tamoxifeni citras","Tomaxasta","Zemide","Zitazonium"],"crossReferences":{"DailyMed":["tamoxifen%20citrate"],"PubChem":["11112087","11112088","124881893","144204489","144209268","144210594","170465425","17389724","26747686","26747687","26747688","26752019","447264","49816809","50107133","85231332"],"chEBI":["9397"]},"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["EFO_0004248","EFO_0003869","EFO_1000403","EFO_0000637","EFO_0001075","EFO_1001901","MONDO_0007254","MONDO_0002087","EFO_0000305","HP_0000771","EFO_1000984","MONDO_0001187","MONDO_0002158","EFO_0000289","EFO_1001375","EFO_0000389","EFO_1000251","EFO_0000326","MONDO_0004976","MONDO_0004647","EFO_1000158","EFO_0001416","EFO_0000616","Orphanet_145","EFO_0000545","MONDO_0004658","MONDO_0008170","EFO_0009907","EFO_1001512","EFO_0000232","MONDO_0018848","EFO_0003843","MONDO_0008315","EFO_0000660","EFO_0000537","EFO_0000311","Orphanet_98896","EFO_0000294","MP_0001914","EFO_0000304","EFO_0004220","EFO_0009708","MONDO_0002691","MONDO_0100096","Orphanet_398934","EFO_0006861","EFO_0000764","MONDO_0011962","Orphanet_774","EFO_0000432","MONDO_0024880","EFO_0003833","EFO_0000519","EFO_0003922"],"count":54},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 3 approved and 44 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL78794","canonicalSmiles":"O=C(O)C(C(=O)O)c1ccccc1","inchiKey":"WWYDYZMNFQIYPT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Phenyl-Malonic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Phenyl-Malonic Acid"],"crossReferences":{"drugbank":["DB04080"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL80","canonicalSmiles":"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5","inchiKey":"UZHSEJADLWPNLE-GRGSLBFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALOXONE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nalone","Narcan","Narcanti"],"synonyms":["Dbl naloxone","NSC-70413","Naloxone","Suboxone"],"crossReferences":{"DailyMed":["naloxone%20hydrochloride"],"PubChem":["144205559","170465008"],"Wikipedia":["Naloxone"],"drugbank":["DB01183"],"chEBI":["7459"]},"childChemblIds":["CHEMBL3186613","CHEMBL1718","CHEMBL1512507"],"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0004240","MONDO_0001583","HP_0000989","EFO_0006834","EFO_0000555","MONDO_0004567","MONDO_0004565","MONDO_0018555","EFO_0003913","EFO_0000474","MONDO_0005180","EFO_0003761","HP_0003419","EFO_0003047","EFO_1000785","EFO_0005762","EFO_0005203","HP_0012532","EFO_0005612","EFO_0010702","EFO_0001073","EFO_0003843","EFO_0000311","EFO_0003890","EFO_0009842","EFO_0005800","MONDO_0005147","EFO_1001051","EFO_0005611","EFO_0004699","EFO_0004270","MONDO_0005178","HP_0002019"],"count":33},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and has 4 approved and 30 investigational indications."}
{"id":"CHEMBL85799","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@H](O)CC[C@]34C)[C@@H]1CCC2=O","inchiKey":"QGXBDMJGAMFCBF-BNSUEQOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETIOCHOLANOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etiocholanolone","Etiocholanone"],"crossReferences":{"PubChem":["56323424","85148331"],"Wikipedia":["Etiocholanolone"],"drugbank":["DB02854"],"chEBI":["28195"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
